Physician

William J Witcik, M.D,

According to 2025 Medicare claims, William Witcik, M.D, (NPI: 1619956547) practices cardiology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE PLLC (NPI: 1982632907; TIN: 421085919) and primary practice location at 52803-2473. Witcik is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Witcik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,887 traditional Medicare patients, billed 6,031 HCPCS/CPT codes, and received $340,387 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 10,607 prescription claims across 1,268 beneficiaries totaling $1,326,386 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 16 claims. Open Payments data shows 6 records totaling $157. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $230,495 to $1,326,386. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,995	7,496	$474,079
2016	3,002	6,971	$429,356
2017	3,119	7,414	$443,287
2018	2,959	7,621	$437,324
2019	2,490	7,162	$411,026
2020	2,159	5,899	$346,845
2021	2,108	6,057	$385,709
2022	2,032	5,636	$344,220
2023	1,890	5,896	$321,748
2024	1,887	6,031	$340,387

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	676	8,847	$230,495
2016	721	8,892	$274,607
2017	743	8,028	$301,704
2018	756	7,327	$359,424
2019	782	7,149	$405,229
2020	842	7,308	$507,163
2021	909	7,966	$685,678
2022	924	8,491	$852,270
2023	996	9,166	$1,041,870
2024	1,268	10,607	$1,326,386

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	16	$943
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	171	171	$112
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	609	625	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	726	1,045	$82
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	640	845	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	620	745	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	556	30,608	$576,349
Xarelto	Rivaroxaban	415	24,837	$449,016
Entresto	Sacubitril/Valsartan	121	5,920	$134,572
Jardiance	Empagliflozin	26	1,560	$26,299
Metoprolol Succinate	Metoprolol Succinate	1,434	110,438	$17,700

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$157	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William J. Witcik, M.D, ?

Tedicare shows public-source Medicare data for William J. Witcik, M.D, (NPI 1619956547), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William J. Witcik, M.D, have ACO affiliation data?

William J. Witcik, M.D, is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to William J. Witcik, M.D, ?

William J. Witcik, M.D, is linked to CARDIOVASCULAR MEDICINE PLLC (billing NPI 1982632907) in the available physician profile data.

Does William J. Witcik, M.D, have Open Payments data?

William J. Witcik, M.D, has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.